✦ LIBER ✦

Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer

✍ Scribed by T. Al-Tweigeri; Rahal; D. Ajarim; A. Al-Sayed; A. Tulba; O. Al-Malik; M. Al-Shabana; H. Al-Hussaina; A. Ezzat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective phase II study of neoadjuvan

✍ Taher A. Al-Tweigeri; Dahish S. Ajarim; Adher A. Alsayed; Mohamed M. Rahal; Moha 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 272 KB

P95 Neoadjuvant Doxorubicin followed seq

✍ A. Ezzat; M. Rahal; D. Ajarim; A. Al-Sayed; A. Tulbah; O. Al-Malik; M. Al-Shaban 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

434 Phase II Study of Neoadjuvant Pegyla

✍ M.K. Tuxen; S. Cold; U.B. Tange; S.B. Soendergaard; D.L. Nielsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase II Study of Neo-adjuvant Gemcitabi

✍ Juan Alejandro Silva; Mario Pérez; Samuel Rivera; Guillermo Olivares; Victor Lir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Phase II study of docetaxel, capecitabin

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase II trial of docetaxel, cisplatin a

✍ Chiarion-Sileni, V; Corti, L; Ruol, A; Innocente, R; Boso, C; Del Bianco, P; Pig 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB